InvestorsHub Logo

sunspotter

04/29/21 7:30 AM

#357392 RE: MrGlasses #357391

"FDA has FAST TRACKED Brilacidin. Should have something ready in 2-3 years."

FDA aren't responsible for researching and developing brilacidin, even if FDA are trying to help by granting FTD with all the facilitation that entails.

The conduct of the studies is IPIX' responsibility, no one else's.

I agree that IPIX has zero sense of urgency in spite of the fact that an early answer to the question of whether brilacidin works or not in COVID-19 would be of great value to the world in general and to COVID-19 sufferers in particular. And to IPIX shareholders of course.

On the other hand a negative outcome would probably result in a grinding halt to Leo Ehrlich's $580k a year gravy train.

So that might account for the glacial pace of this research track.

DrBones

04/29/21 7:38 AM

#357394 RE: MrGlasses #357391

I wonder if that website listed yesterday is selling the correct chemical formula of Brilacidin in India. You can be sure people are buying it as it is listed as a highly effective antiviral on the website. If not a bootleg version, and working, it’s possible to see a grassroots use of drug. A lot of if’s, but that’s all we have to go on now. Patiently waiting...I was able to get my additional 100k